Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Immunology Année : 2017

Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia

Résumé

Helicobacter bilis is a commensal bacterium causing chronic hepatitis and colitis in mice. In humans, enterohepatic Helicobacter spp. are associated with chronic hepatobiliary diseases. Purpose : We aimed at understanding the microbial etiology in a patient with X-linked agammaglobulinemia presenting with suppurative cholangitis. Methods : 16S rDNA PCR directly performed on a liver biopsy retrieved DNA of H. bilis. Results : Clinical outcome resulted in the normalization of clinical and biological parameters under antibiotic treatment by a combination of ceftriaxone, metronidazole, and doxycyclin followed by a 2-week treatment with moxifloxacin and a 2-month treatment with azithromycin. Conclusion : In conclusion, these data suggest a specific clinical and microbiological approach in patients with humoral deficiency in order to detect H. bilis hepatobiliary diseases.
Fichier non déposé

Dates et versions

pasteur-02449154 , version 1 (22-01-2020)

Identifiants

Citer

Nicolas Degand, Justine Dautremer, Benoit Pilmis, Agnès Ferroni, Fanny Lanternier, et al.. Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia. Journal of Clinical Immunology, 2017, 37 (7), pp.727-731. ⟨10.1007/s10875-017-0437-z⟩. ⟨pasteur-02449154⟩

Collections

PASTEUR USPC
23 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More